FMD Multivalent Vaccine
Six-serotype foot-and-mouth disease protection matched to East and Southern African field strains.
FMD costs Africa an estimated $2 billion annually. The vaccine is the most cost-effective intervention available.
FMD is the most economically damaging livestock disease in sub-Saharan Africa. Its presence triggers automatic export restrictions on livestock and livestock products from affected countries. MSD Animal Health's multivalent vaccine covers all six serotypes circulating in the region in a single oil-adjuvanted formulation, supplied by Jos•Hansen with full importation, cold chain and vaccination programme support.
Serotype coverage
Six-serotype formulation covering O, A, Asia-1, SAT-1, SAT-2 and SAT-3. That is the complete profile circulating across East and Southern African livestock. One product, full regional coverage.
Duration of immunity
Primary vaccination establishes six months of solid immunity. A booster at four to six weeks extends protection to twelve months, enabling annual programme scheduling aligned to agricultural calendars.
OIE manufacture
Produced at MSD Animal Health's OIE-accredited facility to international quality standards. Registered with the Directorate of Veterinary Services Kenya and equivalent authorities across Eastern Africa.
FMD closes export markets within days of an outbreak.
A single confirmed FMD outbreak triggers automatic livestock export restrictions under OIE rules. Regional meat markets can remain closed for months while the affected country regains FMD-free status. High-coverage vaccination with a serotype-matched product is the only proven strategy for preventing that outcome at national scale.
Oil adjuvant sustains immunity under field conditions.
The oil adjuvant in MSD's FMD vaccine extends antigen release and amplifies immune response across the temperature variation common during last-mile delivery. Administered subcutaneously or intramuscularly in cattle, sheep and pigs at 2 ml per animal. Booster at four to six weeks, then annual revaccination.
Jos•Hansen delivers the programme, not just the product.
Beyond importation and cold chain, Jos•Hansen designs FMD vaccination programmes: strain surveillance to inform serotype selection, coverage modelling, campaign scheduling and team training. Post-campaign serology monitoring confirms seroconversion and documents herd immunity thresholds for government and donor reporting.
Technical specifications.
Serotypes covered
O, A, Asia-1, SAT-1, SAT-2, SAT-3
Vaccine type
Inactivated, oil-adjuvanted emulsion
Target species
Cattle, sheep, goats, pigs, buffalo
Dose volume
2 ml subcutaneous or intramuscular
Primary immunity
6 months (12 months post-booster)
Storage
2-8°C, never frozen
Manufacturer standard
OIE-recognised facility, KEBS registered
FMD serotypes covered in a single multivalent formulation, the full profile circulating in East and Southern Africa
Estimated annual economic cost of FMD to sub-Saharan Africa including trade restrictions, production losses and herd mortality
Duration of immunity with primary plus booster schedule, enabling annual revaccination aligned to national programme calendars
Why FMD.
Matched serotype selection
Strain surveillance informs serotype selection before each campaign, ensuring the vaccine antigen matches the circulating field challenge.
End-to-end import management
Jos•Hansen handles all regulatory, customs and logistics for FMD vaccine importation including KEBS and DVS clearances.
Cold chain guarantee
2-8°C maintained from MSD's facility to field delivery using SureChill storage and Evermed cold boxes for last-mile integrity.
Programme design included
Coverage modelling, campaign scheduling, team training and post-campaign serology to verify seroconversion, not just vaccine supply.
Partner with Jos Hansen
Talk to our procurement and operations teams about your next infrastructure, healthcare or scientific deployment.